Mitosis is the most conspicuous cell cycle phase, because it is the phase in which the dynamic physical distributions of cellular components into the two daughter cells occur. The separation of sister chromatids is especially important during mitosis, because of the extreme accuracy required for distribution to the next generation of cells. Shugoshinlike 1 (SGOL1) is a key protein in protecting sister chromatids from precocious separation. We have reported finding that chromosome instability is more likely in SGOL1-downregulated colorectal cancers, but it is still unknown whether there is an association between cancer and SGOL1 transcript variation. Here, we identified a novel SGOL1 variant, SGOL1-P1, in human colon cancer. The SGOL1-P1 transcript contains an exon-skip of exon 3 that results in a stop codon occurring within exon 4. Overexpression of SGOL1-P1 in HCT116 cells resulted in an increased number of cells with aberrant chromosome alignment, precociously separated chromatids and delayed mitotic progression, occasionally followed by inaccurate distribution of the chromosomes. These phenotypes, observed when SGOL1-P1 was present, were also observed very frequently in SGOL1-knockdown cells. Furthermore, the overexpression of SGOL1-P1 inhibited the localization of endogenous SGOL1 and cohesin subunit RAD21/SCC1 to the centromere. These results suggest that SGOL1-P1 may function as a negative factor to native SGOL1, and that abundant expression of SGOL1-P1 may be responsible for chromosomal instability.
Introduction
Accurate separation of sister chromatids to opposite poles during mitosis is necessary to ensure euploidy in the daughter cells, because once the sister chromosomes have incorrectly separated, they cannot revert to their original distribution in the normal nucleus. Aberrant distribution of chromosomes into daughter cells induces chromosomal instability (CIN) and often leads to aneuploidy (Rajagopalan and Lengauer, 2004) . CIN frequently occurs in human malignant tumors (Lengauer et al., 1998) and it is a major cause of genomic instability in colorectal cancer (Grady, 2004) . Two causes of CIN have been reported: a defect in the spindle assembly checkpoint (SAC) and a defect in centrosome replication, both of which can be induced by a mutation in a checkpoint gene or by an exogenous agent (Pihan and Doxsey, 1999; Shinmura et al., 2008) . As chromosomes are exposed to the greatest risk of CIN during mitosis, analysis of mitotic progression has become a focus of attention in the field of cancer research (Bharadwaj and Yu, 2004) .
The function of the cohesin complex is to physically bind sister chromatids from the genomic replication phase of the cell cycle until segregation at anaphase (Nasmyth et al., 2000) . Although the bulk of cohesin is removed during prophase and prometaphase, centromere cohesin persists throughout metaphase (Waizenegger et al., 2000) and is finally cleaved by separase during anaphase (Hauf et al., 2001) . Kinetochore fiber microtubules from bipolar spindle poles attach to sister chromatids at the kinetochore. When spindle microtubules fail to attach to the kinetochore, SAC instead functions to prevent premature chromatid segregation. The premature segregation is prevented by the recruitment of SAC proteins to unattached kinetochores, which inhibits the cleavage of cohesin complex through the signaling cascade (Peters, 2002) .
Originally, shugoshin/MEI-S332 (Sgo1) was identified in Drosophila as a mutant, defective in sister chromatid cohesion in meiosis (Goldstein, 1980) and reported to enrich at the centromere until sister chromatids separate (Kerrebrock et al., 1995; Moore et al., 1998) . Further studies revealed that Sgo1 is a protector of Rec8, a component of meiotic cohesin, in yeast (Kitajima et al., 2004; Marston et al., 2004; Rabitsch et al., 2004; Clift et al., 2009 ) and that it is essential for accurate sister chromatid separation during mitosis in vertebrates (Salic et al., 2004; Tang et al., 2004; Kitajima et al., 2005; McGuinness et al., 2005) . Shugoshin-like (SGOL1) protein, the mammalian homolog of shugoshin, interacts with protein phosphatase 2A (PP2A), localizes in the centromeric region and prevents cohesin complex from precocious cleavage at the centromere through dephosphorylation of SA2, one of the cohesin subunits (Kitajima et al., 2006; Riedel et al., 2006) . In a study on human cancer, we found that SGOL1 expression was decreased in colorectal cancer and that SGOL1-knockdown led to CIN in a colon cancer cell line (Iwaizumi et al., 2009) . Furthermore, a crucial link between histone H2A phosphorylation and CIN through shugoshin has recently been discovered (Kawashima et al., 2010) . These reports on shugoshin and SGOL1 indicate that shugoshin is a cross-species guardian at the centromere.
Many tumor-specific splicing products have been studied in a variety of tumors. Although a variantgenerating model in cancer has been suggested (Mayr and Bartel, 2009) , no common theory applicable in all cancers has ever been proposed. In addition to the major splicing variants A1 and A2, 527 and 561 amino acids, respectively, some short variants of SGOL1 have been analyzed, and it has been suggested that the short variants have a negative effect on the cohesion between sister chromatids (Suzuki et al., 2006) . However, no association between disease and SGOL1 transcript variants has ever been shown.
In this paper, we report a novel SGOL1 variant that was detected preferentially in tumor tissue. Forced expression of the tumor-associated variant resulted in abnormal mitotic progression and premature separation between sister chromatids in a colon cancer cell line, as same as in SGOL1-knockdown cells, suggesting that the tumor-associated variant interferes with native SGOL1 and can serve as a target for treatment.
Results

SGOL1-P1 expressed in colon cancer
A variety of SGOL1 variants have been registered in the NCBI protein database (Figure 1a ). To investigate whether there is an association between colon cancer and a particular SGOL1 transcript variant, a reverse transcription-polymerase chain reaction (RT-PCR) was performed with total RNA from specimens of human colon cancer (Figure 1b ). Many types of amplified products were detected from tumor tissue, but only one or two variants were amplified from normal tissue, and several products were cloned and sequenced from tumor tissue. A novel SGOL1 variant named SGOL1-P1 was identified among the sequenced clones derived from the tumor tissue. The sequence data of SGOL1-P1 have been submitted to the DDBJ (DNA Data Bank of Japan) database under accession numbers AB567656 and AB567657. The SGOL1-P1 transcript lacks the exon 3 region and has a frameshift that causes a premature stop codon to occur within exon 4 (Supplementary Figure S1 ). PCR analysis using the primer specific for SGOL1-P1 showed that the prevalence of SGOL1-P1 expression was 6/46 (13.0%) in colon tumors and that no SGOL1-P1 was expressed in the adjacent non-tumor tissue (Figure 1c ). Total expression of other variants, except P1, was lower in the tumor tissue expressing SGOL1-P1 than in paired non-tumor tissues (Figure 1d ), indicating that the emergence of SGOL1-P1 was not caused by acceleration of SGOL1 gene expression. In addition, we isolated 1.75-fold more SGOL1-P1 clones, by a series of procedures including RT-PCR, TA-cloning, and picking and counting the colonies, than the SGOL1-A variants clones from tumors. This result excludes the possibility that the P1 is a rare and artificial transcript in human tumors; instead, it suggests that P1 variant affects the wild type SGOL1 as a dominant negative form in the clinical setting. SGOL1-P1 is composed of 59 amino acids, including the short coiled-coil region determined by the Coils2 program (Lupas et al., 1991) (Figure 1e ). This region is well conserved among vertebrates (Supplementary Figure S2) . Interestingly, the SGOL1-P1-positive tumors were smaller than the SGOL1-P1-negative tumors (Figure 1f) . None of the SGOL1-P1-positive tumors was larger than the average of the tumors as a whole. These results show that SGOL1-P1 is preferentially expressed in colon cancer and that there is a correlation between SGOL1-P1 expression and tumor size.
Aberrant chromosome alignment during mitosis in cells expressing SGOL1-P1 To investigate the effect of SGOL1-P1 on cell division, we overexpressed SGOL1-P1 in HCT116 cells, human colorectal cancer cells, and observed the mitotic cells. Interestingly, the chromosome mass in the SGOL1-P1-transfected cells appeared spread out and not to be precisely aligned with the metaphase plate (Figure 2a ). According to previous papers, aberrant chromosome alignment was observed in SGOL1-knockdown cells (Salic et al., 2004; Tang et al., 2004; Kitajima et al., 2005 Kitajima et al., , 2006 . We therefore analyzed chromosome alignment at prometaphase and metaphase in detail in the present study in order to investigate the function of SGOL1-P1. For this analysis, chromosome alignment index was calculated on the basis of the shape of chromosomal mass (Figures 2a and b) . The results of the morphometric analysis of the images acquired in the present study showed that the frequency distributions of the chromosome alignment index values of SGOL1-knockdown cells (SGOL1 RNAi) and SGOL1-P1-overexpressing cells were lower than those of the control cells (control RNAi) and the cells transfected with empty vector, respectively (Figures 2c-f) . These results indicate that SGOL1-P1 overexpression leads to aberrant chromosome alignment, the same way as SGOL1-knockdown does. When the chromosomal mass is not positioned parallel to the horizontal plane, the calculated index value may not be appropriate for estimating the deviation of the chromosomes from the metaphasic plate. However, the distributions of the angles of the spindle bodies relative to the horizontal plane were similar among the various groups of cells that were examined (Supplementary Figure S3) . Thus, the angle of the chromosomal mass relative to the horizontal plane may not have influenced the calculated index values in the present study.
Delayed mitotic progression in cells expressing SGOL1-P1 As the aberrant alignment in Figure 2a resembled the mitotic progression defect observed in SGOL1-knockdown cells reported previously (Salic et al., 2004; McGuinness et al., 2005) , we performed time-lapse imaging to investigate the aberrant chromosome alignment, and we used GFP-histone H2B to observe the chromosome dynamics in living cells (Kanda et al., 1998) . Measurements of the time taken to progress from prophase to anaphase revealed severe mitotic arrest in SGOL1-knockdown cells (Figure 3a) . It took 50 min or more for 50% of the cells (52/105) to move from prophase to anaphase. Most of the cells exhibiting this delayed phenotype (34/52, 65.4%) had not reached anaphase within the observation period, because prometaphase or metaphase had lasted several hours or more. The cells transfected with SGOL1-P1 also showed a progression delay compared with the cells transfected with SGOL1-A1 and the cells transfected with the empty control vector (Figure 3b ). The subfraction of cells whose progression time between prophase and anaphase was 50 min or more was larger among the cells . These results show that SGOL1-P1 expression prevents mitotic progression to anaphase and causes inaccurate chromosome distribution.
Decrease in centromeric localization of endogenous SGOL1 in cells expressing SGOL1-P1 Overexpressed SGOL1-P1 was localized in both the cytoplasm and the nucleus at interphase and outside the chromosomes during mitosis (Figure 4a ). Furthermore, SGOL1-P1 was abundantly present even at anaphase ( Figure 4a and Supplementary Figure S4a ), whereas endogenous SGOL1 was not observed as described previously (Salic et al., 2004) . SGOL1-P1 lacks the motifs for destruction that are present in the long form of SGOL1 ( Figure 1e ; Karamysheva et al., 2009) . Therefore, the result that SGOL1-P1 was abundantly present at anaphase is consistent with its amino acid sequence. In some cases, abnormal segregations of chromosomes, such as that shown in Figure 3e , were observed in the SGOL1-P1-expressing cells (Figure 4a) . The cyclin B1 level in cells exhibiting abnormal chromosome segregation was higher than that in cells exhibiting typical anaphase and similar to the level observed in metaphase cells (Supplementary Figure  S4b) . The anaphase-promoting complex/cyclosome (APC/C), which is a ubiquitin-ligase and targets cellcycle-related proteins (including cyclin B1) for degradation by the 26S proteasome and promotes exit from metaphase, is suppressed during SAC activation (Wasch et al., 2010) . Therefore, our results show that abnormal chromosome segregation did not follow the degradation of cyclin B1, suggesting that SAC remains activated in cells in which abnormal chromosome segregation occurs. To investigate the effect of SGOL1-P1 on endogenous SGOL1 at mitosis, we performed a coimmunofluorescence study for the centromere, endogenous SGOL1 and myc-SGOL1-P1. Interestingly, we found that the endogenous SGOL1 signals at the centromere decreased in the SGOL1-P1-expressing cells (Figure 4b ), where the metaphasic chromosomes had a defective alignment as shown in Figure 2 . Because SGOL1 prevents cohesin from precocious cleavage at the centromere, we investigated whether RAD21/SCC1, a cohesin subunit, was localized at the centromere. The signals of RAD21 at the centromere also decreased in the SGOL1-P1-expressing cells with the alignment defect (Figure 4c) , whereas the signals of PP2A-B56a, a regulatory subunit of the PP2A complex, did not ( Figure 4d ). These results show that SGOL1-P1 inhibits the localization of native SGOL1 and RAD21 to the centromere, independently of PP2A.
Cohesion defects between sister chromatids in cells expressing SGOL1-P1
The result that RAD21 decreased at the centromere in SGOL1-P1-expressing cells reminded us that cohesion A novel SGOL1 variant involved in colon cancer T Kahyo et al defect between sister chromatids occurred. To assess the effect of SGOL1-P1 on sister chromatid cohesion, a chromosome spread assay was performed. Spread chromosomes were stained with DAPI ( Figure 5a ) and the frequency of the each of the separation patterns was counted ( Figure 5b ). The SGOL1-knockdown cells exhibited a high frequency of severe cohesion defects between sister chromatids, the same as described previously (Tang et al., 2004; Kitajima et al., 2005; McGuinness et al., 2005) . Severe cohesion defects were also observed in 11% of the SGOL1-P1-expressing cells, but they were rarely found in the control cells. Cells defecting cohesion between sister chromatids are prone to develop CIN as a result of failure of mitotic progression. Because HCT116 cells have a relatively stable karyotype (45 chromosomes; Kienitz et al., 2005) , the total number of chromosomes per cluster can be counted. The frequency of the aberrant phenotype, which we defined as a cluster composed of more than 50 chromosomes, was significantly higher in the A novel SGOL1 variant involved in colon cancer T Kahyo et al SGOL1-knockdown cells (P ¼ 0.037, Fisher's exact test), and the frequency of the phenotype tended to be higher in the SGOL1-P1-expressing cells than in the control cells (P ¼ 0.097) (Figures 5c and d) . These results mean that SGOL1-P1 participates in the precocious separation of sister chromatids and is capable of inducing CIN in the process of cell proliferation.
Abnormal cell phenotypes in the stable cell lines expressing SGOL1-P1 To examine the effects of SGOL1-P1 expression during long-term culture, we established cell lines stably expressing SGOL1-P1 (P3-2 and P4-1) from HCT116 cells (Figure 6a ). These cell lines exhibited a slightly higher mitotic frequency, particularly in prometaphase/ metaphase, than the parental cell and the stable cell line transfected with the empty vector (Table 1 and Figure 6b ). They were also observed to exhibit delayed mitotic progression (Supplementary Figure S5a) and chromosome separation without congression at the metaphase plate when examined by time-lapse fluorescence microscopy ( . Endogenous SGOL1 and myc-SGOL1-P1 were detected using immunofluorescence with mouse antihSgo1 and rabbit anti-myc antibodies, respectively. (c, d) Localization of endogenous RAD21 and PP2A-B56a on chromosomes in cells expressing SGOL1-P1. For the immunostaining of RAD21 and PP2A-B56a, the cells were fixed with paraformaldehyde, followed by spinning down on a glass coverslip and pre-extraction with a detergent. The centromere was detected using immunofluorescence with human anti-centromere autoantibody (b, c). The inset is a magnified image of the centromere. Scale bar ¼ 10 mm.
Abnormal nuclear shape is known to reflect CIN and to be frequently observed in malignant tumors (Gisselsson et al., 2001 ). The stable cell lines expressing SGOL1-P1 exhibited less circularity and more frequent micronuclei (Table 1 and Figures 6c and d) . We examined cells for the presence of an extra centrosome, because multiple spindle poles have been reported to be common in mitotic SGOL1-knockdown cells (Kitajima et al., 2006; Dai et al., 2009 ). An extra centrosome was observed more frequently in the cell lines expressing SGOL1-P1 (Table 1 and Figure 6e ). Triple daughter nuclei, caused by multiple spindle formation, were also observed almost exclusively in cells expressing SGOL1-P1 (Supplementary Figure S5c and Supplementary Movie 5). We suspected that the culture time of several days shown in Figure 5d was not long enough to induce a full-blown aberrant phenotype in the SGOL1-P1-expressing cells. The increased number of chromosomes mentioned here reflects the aberrant distribution of chromosomes preceding mitosis. Thus, a shorter culture time may not yield sufficient chromosome aberrations from the previous mitosis. Therefore, we examined the number of chromosomes in SGOL1-P1-stably expressing cells, which had passed through more mitotic phases. In addition to the premature separation of sister chromatids, an aberrant number of chromosomes was observed more frequently in cells expressing SGOL1-P1 than in the parent cells (Figures 6f and g ). These results indicate that long-term expression of SGOL1-P1 affects nuclear shape, centrosome stability and CIN. Discussion SGOL1-P1 was identified as a novel tumor-specific variant and the SGOL1-P1-positive tumors were smaller than the SGOL1-P1-negative tumors. Because the outcome of the SGOL1-P1-positive cases is still unknown, the relationship between SGOL1-P1 expression and the prognosis remains unclear. As our observations in this study showed that SGOL1-P1 expression induced the HCT116 aberrant karyotype, abnormal nuclear shapes and micronuclei, all of which are indicative of the highly malignant nature of the tumor cells, SGOL1-P1 may drive early stage tumors toward a more aggressive phenotype. After SGOL1-P1 has driven a small benign tumor to undergo malignant transformation, it may not be required for tumor progression. SGOL1-P1 would rarely be observed in an advanced tumor. This model, in which SGOL1-P1 causes malignancy in the early stage of colon cancer, may be applicable to other types of cancer because SGOL1-P1 was also detected in lung cancer (Supplementary Figure S6) . Comprehensive analysis of the role of SGOL1-P1 is now under way in lung cancer. 
A novel SGOL1 variant involved in colon cancer T Kahyo et al
The concept that tumors are composed of a heterogeneous population of cells has been established (Reya et al., 2001) . Cancer stem cells (CSCs) exhibit both properties of self-renewal and differentiation into diverse cancer cell types and they are thought to be responsible for tumors being composed of a heterogeneous population of cells. When chromosomal abnormalities occur in CSCs, the phenotypic diversity of the cells in a tumor may increase and have a negative impact on the outcome, because of the acquisition of malignant properties, such as drug resistance and metastasis. Therefore, it is also expected that shugoshin studies will be performed in the field of CSCs in order to investigate its impact on tumor progression.
Aberrant chromosome alignment at the metaphase plate is thought to be due to unstable chromatid cohesion. It has A novel SGOL1 variant involved in colon cancer T Kahyo et al recently been reported that a mono-oriented chromosome is transported toward the metaphase plate along the kinetochore fiber that has already attached to the bioriented chromosomes remaining at the metaphase plate (Kapoor et al., 2006) , and that cohesion between chromatids at the centromere influences kinetochore geometry and determines kinetochore orientation (Sakuno et al., 2009) . Therefore, inappropriate kinetochore orientation is thought to cause the defect in transport to the metaphase plate and result in the aberrant chromosome alignment in cells expressing SGOL1-P1. The number of cells that contained an extra centrosome increased in the presence of SGOL1-P1 in our experiment. This finding was consistent with the results of a previous study in which spindle pole integrity was found to require chromosome cohesion (Dai et al., 2009) . In that study, knockdown of haspin, SGOL1 or RAD21, all of which are necessary for chromosome cohesion, resulted in an increase in the number of g-tubulin foci. Thus, the overexpression of SGOL1-P1 should also impair centrosome stability by interfering with chromatid cohesion. This is the first study to report an association between cancer and a SGOL1 variant. As SGOL1-P1 expression inhibited the localization of endogenous SGOL1 and RAD21 to the centromere in our experiments, SGOL1-P1 is thought to function as a negative factor to native SGOL1. Although the details of the molecular mechanism mediated by SGOL1-P1 remain unclear, a protein-protein interaction with an, as yet, unidentified protein is assumed to be involved in the mechanism. SGOL1-P1 is composed of 59 amino acids, and the region of SGOL1-A1 protein (amino acids 1-47) encoded by exon 1 and exon 2 of the SGOL1 gene accounts for 79.7% of the amino acid sequence of SGOL1-P1. Having the amino acid sequence 51-96 is sufficient for SGOL1 to bind PP2A (Xu et al., 2009) . This amino acid region is within the exon 3-coded region (aa 48-113), and SGOL1 mutant N61I actually does not exhibit binding activity to PP2A (Tang et al., , 2006 Xu et al., 2009) . Thus, PP2A is probably not a target of SGOL1-P1. Actually, the localization of PP2A-B56a on chromosomes was not affected by SGOL1-P1 expression, even in cells with a reduction in RAD21 signals. Similarly, heterochromatin protein HP1a, a SGOL1-interacting protein that is required for localization and functioning of SGOL1 at the centromere does not seem to be a target either, because the binding region of SGOL1 to HP1a is located in the C-terminal area (Yamagishi et al., 2008) . As it is more likely that SGOL1-P1 inhibits the interaction between native SGOL1 and as yet unidentified targets, we are currently searching for proteins that interact with SGOL1-P1.
There is also the possibility that the SGOL1-P1-unique sequence may be involved in abnormal chromosome alignment. The C-terminal short region of SGOL1-P1 corresponds to exon 4 in the frameshift and this frameshift is what makes the SGOL1-P1 sequence unique among SGOL1 variants. Interestingly, a BLAST search of the NCBI's protein database revealed that the C-terminal unique sequence of SGOL1-P1 is similar to the conserved region of the Polo-like kinase (Plk) family. The part of the sequence in the Plk family proteins that is similar to the C-terminal unique sequence of SGOL1-P1 and the adjacent residues are conserved among species and form a catalytic loop (Supplementary Figure S7 ; Kothe et al., 2007) . The results of the NCBI's Conserved Domains Database search also suggested that the Plk1 catalytic loop includes ATP-and substrate-binding sites (accession number cd05123), and thus SGOL1-P1 may interfere with Plk1-mediated phosphorylation through the conserved region described above. If this model, in which SGOL1-P1 targets Plk1, is correct, the abnormal chromosome alignment and the precociously separated chromatids found in the SGOL1-P1-expressing cells should be independent of each other, because Plk1 is required for assembly of the mitotic spindle, but not for chromatid cohesion (Losada et al., 2002; Sumara et al., 2002 Sumara et al., , 2004 Eot-Houllier et al., 2008) . The spatiotemporal function of SGOL1-P1 in relation to Plk1 and native SGOL1 may cause the abnormal mitotic phenotypes observed in the present study.
The results of the present study demonstrated an association between SGOL1-P1 and colon cancer, and they suggest that native SGOL1 is deregulated by SGOL1-P1. Further studies, such as studies of SGOL1-P1 expression in other types of cancer, of the mechanism of generation of SGOL1-P1 transcripts and of the molecular targets of SGOL1-P1, should improve our understanding of how tumors are generated and become malignant.
Materials and methods
RT-PCR and plasmid construction
RT-PCR was carried out as described in our previous report (Iwaizumi et al., 2009) . The primer sequences used for the first RT-PCR ( Figure 1b) were 5 0 -GGAGGAGGAAGATAG CTGTTGC-3 0 (sense) and 5 0 -TATGGCAATGGCTCACTC TG-3 0 (antisense). The PCR products from non-tumor tissue and tumor tissue were cloned and used for the sequence analysis. A primer targeting the junction between exon 2 and exon 4 was constructed for routine detection of SGOL1-P1 transcripts in specimens (Supplementary Figure S1) . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified as an internal control, and the quantitative real-time RT-PCR was carried out as described previously (Iwaizumi et al., 2009) . To express SGOL1-P1 in mammalian cells, six myc tags were fused to the N-terminus of SGOL1-P1 and the product was inserted into pcDNA3.1. The pSilencer plasmid with short hairpin RNA (shRNA) targeting the SGOL1 sequence was used for the RNA interference (RNAi) procedure as described previously (Iwaizumi et al., 2009) .
Cell culture and transfection
Human colon cancer cell line HCT116 was cultured at 37 1C in RPMI medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (Nichirei, Tokyo, Japan), under 5% CO 2 . Transfection was performed by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Stable cell lines expressing myc-SGOL1 (A1 or P1) were generated by incubating the transfected cells in selection medium containing 200 mg/ml geneticin (Invitrogen) and performing limiting-dilution cloning. Cells subcultured for 25-45 passages were used in the experiments.
Antibodies
Rabbit polyclonal anti-shugosin (ab21633; Abcam, Cambridge, MA, USA; Figure 2c ), anti-myc tag (06-549; Millipore, Bedford, MA, USA) and anti-Rad21 antibodies (ab992; Abcam; Figure 4d ), mouse polyclonal anti-PPP2R5A antibodies (PP2A-B56a) (H00005525-B01P; Abnova, Taipei, Taiwan) and mouse monoclonal anti-b-tubulin (2-28-33; Sigma, St Louis, MO, USA), anti-hSgo1 (Figure 4b) , and anti-Rad21 (53A303; Millipore; Figure 4c ) and anti-g-tubulin antibodies (GTU88; Sigma) were used for immunoblotting and immunofluorescence staining. Human autoantibody against the centromere (Immunovison, Springdale, AR, USA) was used for immunofluorescence staining of kinetochore. HRPconjugated donkey polyclonal anti-rabbit antibody or antimouse IgG antibody (GE Healthcare, Piscataway, NJ, USA) and Alexa Fluor 488/546/633-conjugated goat polyclonal antirabbit, anti-mouse or anti-human IgG antibodies (Invitrogen) were used as secondary antibodies.
Immunoblotting Immunoblotting was performed as described previously (Kahyo et al., 2008) . Briefly, the protein concentration of the lysate was measured with a BCA protein assay kit (Thermo Scientific, Rockford, IL, USA). Following the addition of SDS sample buffer, the samples were boiled at 95 1C for 5 min and they were then subjected to SDS-polyacrylamide gel electrophoresis. Cell lysate of 10 mg was loaded on the gel.
Confocal laser scanning
Cells plated on fibronectin-coated glass coverslips (Becton Dickinson, Franklin Lakes, NJ, USA) were transfected with myc-SGOL1 or shRNA of SGOL1 and cultured for 24 h. The cells were cultured in presence of puromycin (0.8 mg/ml, Sigma) for RNAi or geneticin (200 mg/ml) for the expression assay. After culture for 48 h, they were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) buffer (140 mM NaCl, 2.7 mM KCl, 8.1 mM sodium phosphate dibasic and 1.5 mM potassium phosphate monobasic) at room temperature for 15 min, permealized with 0.1% Triton X-100 and subjected to immunostaining. For g-tubulin, staining cells were fixed with cold methanol at À20 1C for 5 min. To detect RAD21 and PP2A-B56a signals on the chromosomes clearly, we referred to previous reports (Waizenegger et al., 2000; Kitajima et al., 2006; Lee et al., 2008) . Briefly, cultured cells were spun on a glass coverslip for 5 min at 290 g and pre-treated with 0.1% Triton X-100 in PBS at room temperature for 2 min before fixation with 4% paraformaldehyde. All of the cells were stained with 1.5 mg/ml 4 0 ,6-diamidine-2-phenylindole (DAPI, Invitrogen) to visualize their nuclei. Fluorescence signals were detected by confocal laser scanning microscopy (FV1000; Olympus, Tokyo, Japan). The lengths of horizontal and vertical axes were measured with Image J software (version 1.43f; National Institutes of Health, Bethesda, MD, USA).
Chromosome spread
Transfected cells were selected with antibiotics as described above. After culture for 48 h, the cells were treated with 100 nM nocodazole (Sigma) for 18 h. They were then trypsinized and collected by centrifugation in a conical tube. The cells were gently suspended with hypotonic solution (75 mM KCl) and incubated at 37 1C for 6 min. Chilled fixative solution (methanol:glacial acetic acid, 3:1) was gently added to the cells that had been collected by centrifugation, and this procedure consisting of centrifugation, collection of the cells and addition of chilled fixative solution was repeated three times. The fixed cells were dropped onto the slide glasses. After drying in air, they were stained with DAPI.
Time-lapse imaging
Myc-SGOL1 and GFP-Histone H2B plasmids were used to cotransfect HCT116 cells plated on the fibronectin-coated glassbottom dishes, and 48 h later, the medium was replaced with fresh medium and the cells were subjected to time-lapse imaging (FCV100; Olympus). Fluorescence signals from GFP were captured at 5 min intervals for 24 h and the data were used to prepare the montage images and movies.
Statistical analysis
The Mann-Whitney U-test was used to statistically analyze non-parametric data. The w 2 -test or Fisher's exact test was used to compare categorical variables. The statistical analysis was performed by using the Microsoft Excel software program (Microsoft, Redman, WA, USA).
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